The product's shortlist

Sell the best-scored name

This strategy sells short. Every return below is the position's — the stock's move with the sign reversed. It is a measurement of where the system's information lives, not a recommendation to sell anything.

Sessions

first reading at 60

Mean return

-5.01%

Open to close, per session

vs S&P 500

-5.04%

t = -0.73

Verdict

no verdict yet

11 of the 60 sessions before the first reading. No verdict until then.

The hypothesis, as registered

The bench's only short. The screen may not be producing a buy list but a list of names that have already moved: on twelve sessions the finalist with the top quantitative score lost 5.9% a day on average. If selling it earns what buying it loses, the information in this system lives on the downside — and the disagreement between screen and jury is worth more than their agreement. This is a measurement, not a recommendation to sell anything.

The rule

Sell short the finalist with the highest re-scored quantitative score — the same name 'Shortlist, numbers only' buys — and hold to the close. The recorded return is the position's: the stock's move with the sign reversed, and against the S&P 500 likewise.

Registered on 2026-09-25. Neither text has changed since, and neither will: a strategy that needs amending is retired and a new one registered in its place.

Session by session

Newest first. The numbers in the middle column are the ones the rule actually read that morning. Losing days stay.

Session	Pick	What the rule read	Return	vs S&P 500
2026-10-14	VRAVera Bradley, Inc.	quant score 59.3 · 1-day return +5.86% · pre-market gap +0.52% · model consensus 49.2	pending	pending
2026-10-13	CCCCCC Intelligent Solutions Holdings Inc.	quant score 72.9 · 1-day return +8.12% · pre-market gap -0.53% · model consensus 64.7	+2.49%	+2.40%
2026-10-12	NVAXNovavax, Inc.	quant score 72.7 · 1-day return +15.80% · pre-market gap -1.02% · model consensus 61.2	no price found	—
2026-10-09	MANEVeradermics, Incorporated	quant score 78.8 · 1-day return +14.13% · model consensus 73	+4.13%	+3.83%
2026-10-08	XRPNArmada Acquisition Corp. II	quant score 74.0 · 1-day return +30.26% · pre-market gap +6.00% · model consensus 61.7	no price found	—
2026-10-07	APUSApimeds Pharmaceuticals US, Inc.	quant score 79.0 · 1-day return +55.34% · pre-market gap +11.92% · model consensus 51	-11.88%	-12.06%
2026-10-06	DNAGinkgo Bioworks Holdings, Inc. Class A	quant score 78.4 · 1-day return +21.30% · pre-market gap +2.03% · model consensus 61.7	-17.71%	-17.83%
2026-10-05	SDEVStablecoin Development Corporation	quant score 85.7 · 1-day return +104.37% · pre-market gap +52.08% · model consensus 51.2	-59.42%	-60.09%
2026-10-02	XRPNArmada Acquisition Corp. II	quant score 82.1 · 1-day return +42.87% · pre-market gap +7.17% · model consensus 65.2	+35.93%	+36.05%
2026-10-01	PGENPrecigen, Inc.	quant score 82.2 · 1-day return +6.34% · pre-market gap +1.05% · model consensus 62.7	-3.41%	-3.36%
2026-09-30	IOVAIovance Biotherapeutics, Inc.	quant score 88.3 · 1-day return +31.48% · pre-market gap +1.66% · model consensus 53.2	+0.89%	+1.38%
2026-09-29	AGENAgenus Inc.	quant score 76.0 · 1-day return +10.42% · pre-market gap +1.29% · model consensus 62	+3.24%	+3.58%
2026-09-28	QMCOQuantum Corporation	quant score 78.3 · 1-day return +7.43% · pre-market gap -1.04% · model consensus 39.7	-0.79%	-0.43%
2026-09-25	GLNDGreenland Energy Company	quant score 94.0 · 1-day return +83.85% · pre-market gap +18.13% · model consensus 64	-8.58%	-8.92%

Best session +35.93%, worst -59.42%. Over this few sessions the mean is mostly the sum of its two or three largest days, which is the whole reason the verdict is read only after 60, 120, 250, 500 sessions and frozen in between.

This is not investment advice. Tickbird is an automated experiment. It publishes a general analysis, not a personal recommendation, and it makes no promise about any outcome. Past results do not predict future ones. Never risk money you cannot afford to lose.